Wei-Mei Ching Selected Research

Infections

12/2020	Regulation of Serum Exosomal MicroRNAs in Mice Infected with Orientia tsutsugamushi.
1/2020	Temporal analysis of mRNA expression profiles in Orientia infected C3HeB/FeJ mouse.
4/2010	Epidemiology of spotted fever group and typhus group rickettsial infection in the Amazon basin of Peru.
2/2010	Accuracy of AccessBio Immunoglobulin M and Total Antibody Rapid Immunochromatographic Assays for the Diagnosis of Acute Scrub Typhus Infection.
11/2005	Protection against scrub typhus by a plasmid vaccine encoding the 56-KD outer membrane protein antigen gene.
5/2004	Proteome analysis of Madrid E strain of Rickettsia prowazekii.
4/2004	Development of a quantitative real-time polymerase chain reaction assay specific for Orientia tsutsugamushi.
7/2003	Laboratory diagnosis of two scrub typhus outbreaks at Camp Fuji, Japan in 2000 and 2001 by enzyme-linked immunosorbent assay, rapid flow assay, and Western blot assay using outer membrane 56-kD recombinant proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Mei Ching Research Topics

Disease

18	Scrub Typhus (Typhus, Scrub) 01/2022 - 11/2002
8	Infections 12/2020 - 07/2003
6	Epidemic Louse-Borne Typhus (Typhus) 12/2017 - 05/2004
3	Q Fever (Fever, Q) 01/2022 - 06/2010
3	Leptospirosis 01/2022 - 01/2017
3	Fever (Fevers) 01/2017 - 05/2009
2	Endemic Flea-Borne Typhus (Typhus, Endemic Flea Borne) 01/2022 - 04/2008
2	Spotted Fever Group Rickettsiosis (Rickettsialpox) 01/2022 - 04/2010
1	Virus Diseases (Viral Diseases) 12/2020
1	Chickenpox 01/2020
1	Infertility (Sterility) 01/2020
1	Measles 01/2020
1	Mumps 01/2020
1	Rubella (German Measles) 01/2020
1	Tuberculosis (Tuberculoses) 12/2017
1	Anaplasmosis 12/2017
1	Coinfection 06/2011

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2017 - 04/2004
7	VaccinesIBA 01/2020 - 08/2005
7	Immunoglobulin M (IgM)IBA 10/2017 - 11/2002
7	Proteins (Proteins, Gene)FDA Link 05/2015 - 12/2005
7	Membrane Proteins (Integral Membrane Proteins)IBA 01/2014 - 04/2004
6	Immunoglobulin G (IgG)IBA 10/2017 - 11/2002
5	AntibodiesIBA 01/2022 - 02/2010
3	Recombinant ProteinsIBA 10/2017 - 07/2003
3	ImmunosorbentsIBA 04/2008 - 11/2002
3	EnzymesIBA 04/2008 - 11/2002
2	Doxycycline (Periostat)FDA LinkGeneric 05/2009 - 07/2003
2	DNA VaccinesIBA 12/2005 - 11/2005
1	MicroRNAs (MicroRNA)IBA 12/2020
1	Culture MediaIBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 12/2017
1	StreptavidinIBA 01/2014
1	PolymersIBA 01/2014
1	Peroxidase (Myeloperoxidase)IBA 01/2014
1	Biological ProductsIBA 12/2012
1	EpitopesIBA 06/2009
1	Peptides (Polypeptides)IBA 06/2009
1	Chloramphenicol (Chloromycetin)FDA Link 05/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2009
1	Combined VaccinesIBA 12/2005
1	AerosolsIBA 05/2004
1	Biological Warfare AgentsIBA 05/2004
1	DNA (Deoxyribonucleic Acid)IBA 04/2004

Therapy/Procedure

1	Therapeutics 01/2018